Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease.

PubWeight™: 1.52‹?› | Rank: Top 4%

🔗 View Article (PMID 24112401)

Published in J Sex Med on September 24, 2013

Authors

Martin Gelbard1, Wayne J G Hellstrom, Chris G McMahon, Laurence A Levine, Ted Smith, James Tursi, Gregory Kaufman, Irwin Goldstein

Author Affiliations

1: Urology Associates Medical Group, Burbank, CA, USA.

Articles by these authors

Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol (2013) 4.58

The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc (2012) 3.45

Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet (2006) 3.23

Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors. J Am Coll Cardiol (2012) 2.85

Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. J Hand Surg Am (2012) 2.56

RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A (2004) 2.53

Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease. J Urol (2012) 2.27

Penile constriction devices: case report, review of the literature, and recommendations for extrication. J Sex Med (2008) 2.19

Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women. Menopause (2012) 2.09

Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip. Lancet (2002) 2.02

Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J Sex Med (2014) 1.99

An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med (2008) 1.95

An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE). J Sex Med (2014) 1.91

Transplantation of nonhematopoietic adult bone marrow stem/progenitor cells isolated by p75 nerve growth factor receptor into the penis rescues erectile function in a rat model of cavernous nerve injury. J Urol (2010) 1.84

Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol (2005) 1.83

Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol (2007) 1.79

A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol (2013) 1.70

Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med (2006) 1.66

Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol (2002) 1.65

Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction. J Sex Med (2006) 1.63

That's one small step for medicine, one giant leap for sexual medicine. J Sex Med (2007) 1.63

International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med (2010) 1.60

Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats. Biochem Biophys Res Commun (2002) 1.53

Interrelationship of sildenafil treatment effects on the physiological and psychosocial aspects of erectile dysfunction of mixed or organic etiology. J Sex Med (2010) 1.53

Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study. J Sex Med (2013) 1.53

Gene therapy for erectile dysfunction: fact or fiction? Eur Urol (2006) 1.51

Ketoconazole and prednisone to prevent recurrent ischemic priapism. J Urol (2009) 1.51

The effect of vascular risk factors on penile vascular status in men with erectile dysfunction. J Urol (2007) 1.49

Erectile dysfunction diagnosis and treatment as a means to improve medication adherence and optimize comorbidity management. J Sex Med (2012) 1.47

The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. J Sex Med (2008) 1.44

Peripheral mechanisms of erectile dysfunction in a rat model of chronic cocaine use. Eur Urol (2007) 1.44

Androgen deprivation therapy impact on quality of life and cardiovascular health, monitoring therapeutic replacement. J Sex Med (2013) 1.43

Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2010) 1.42

Aspiration and sclerotherapy: a nonsurgical treatment option for hydroceles. J Urol (2012) 1.41

Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction. Am J Physiol Heart Circ Physiol (2006) 1.41

Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes. J Sex Med (2013) 1.40

An old problem with a new cause-5 alpha reductase inhibitors and persistent sexual dysfunction. J Sex Med (2011) 1.40

Summary of the recommendations on sexual dysfunctions in women. J Sex Med (2004) 1.40

Validity of the decreased sexual desire screener for diagnosing hypoactive sexual desire disorder. J Sex Marital Ther (2013) 1.40

Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl (2003) 1.37

Disorders of orgasm and ejaculation in men. J Sex Med (2010) 1.35

Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril (2002) 1.35

Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase. Am J Physiol Heart Circ Physiol (2006) 1.34

Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl (2003) 1.32

The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study. J Gen Intern Med (2005) 1.28

Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues. J Sex Med (2012) 1.23

Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep. Pharmacogenetics (2003) 1.22

Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol (2003) 1.22

Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms. J Sex Med (2012) 1.22

Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med (2005) 1.21

Bother and distress associated with Peyronie's disease: validation of the Peyronie's disease questionnaire. J Urol (2013) 1.20

Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder. J Sex Med (2012) 1.19

Bicycle riding and erectile dysfunction: a review. J Sex Med (2010) 1.17

Multipotent stromal cell therapy for cavernous nerve injury-induced erectile dysfunction. J Sex Med (2011) 1.14

Cardiac uses of phosphodiesterase-5 inhibitors. J Am Coll Cardiol (2012) 1.13

Validation of the erection hardness score. J Sex Med (2007) 1.11

Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease. J Sex Med (2011) 1.11

Superoxide anion production in the rat penis impairs erectile function in diabetes: influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med (2005) 1.10

An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. J Sex Med (2014) 1.10

The efficacy of sildenafil citrate (Viagra) in clinical populations: an update. Urology (2002) 1.10

Re: long-term infection outcomes of 3-piece antibiotic impregnated penile prostheses used in replacement implant surgery. J Urol (2012) 1.08

An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. BJU Int (2008) 1.07

Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease. Am J Kidney Dis (2006) 1.06

Current concepts in the management of erectile dysfunction in men with prostate cancer. Clin Prostate Cancer (2004) 1.06

Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options. Expert Opin Pharmacother (2011) 1.05

Adipose tissue-derived stem cell-seeded small intestinal submucosa for tunica albuginea grafting and reconstruction. Proc Natl Acad Sci U S A (2012) 1.04

Effects of medical or surgical castration on erectile function in an animal model. J Androl (2003) 1.03

Correlates to the clinical diagnosis of premature ejaculation: results from a large observational study of men and their partners. J Urol (2007) 1.03

Infection retardant coated inflatable penile prostheses decrease the incidence of infection: a systematic review and meta-analysis. J Urol (2012) 1.02

Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial. J Urol (2007) 1.02

Modulation of rat vaginal blood flow and estrogen receptor by estradiol. J Urol (2004) 1.01

Microsurgical denervation of the spermatic cord for chronic orchialgia: long-term results from a single center. J Urol (2008) 1.01

Surgical correction of Peyronie's disease via tunica albuginea plication or partial plaque excision with pericardial graft: long-term follow up. J Sex Med (2008) 1.01

Cardiometabolic risk and female sexual health: the Princeton III summary. J Sex Med (2012) 1.01

Only the nose knows: penile hemodynamic study of the perineum-saddle interface in men with erectile dysfunction utilizing bicycle saddles and seats with and without nose extensions. J Sex Med (2005) 1.00

Differential effects of estradiol, progesterone, and testosterone on vaginal structural integrity. Endocrinology (2005) 1.00

Bicycle riding and erectile dysfunction: an increase in interest (and concern). J Sex Med (2005) 0.99

Factors affecting the loss of length associated with tunica albuginea plication for correction of penile curvature. J Urol (2006) 0.99

Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction. Curr Opin Investig Drugs (2006) 0.99

The hydrophilic-coated inflatable penile prosthesis: 1-year experience. J Sex Med (2004) 0.98

Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med (2007) 0.98

Peyronie's Disease. Urol Clin North Am (2007) 0.98

Managing the difficult penile prosthesis patient. J Sex Med (2013) 0.97

Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. J Urol (2013) 0.97

Penile injection with silicone: case report and review of the literature. J Sex Med (2008) 0.97

The pharmacological treatment of premature ejaculation. BJU Int (2008) 0.97

Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction. Expert Opin Pharmacother (2010) 0.97